50.71
Finanzdaten der Mbx Biosciences Inc-Aktie (MBX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
50.12%
40.93
|
27.27 | 25.80 | 23.93 | 21.80 |
| Operating Income/Loss |
50.12%
-40.93
|
-27.27 | -25.80 | -23.93 | -21.80 |
|
|
57.74%
-37.09
|
-23.52 | -22.06 | -21.62 | -19.41 |
| Basic Average Shares |
2.41%
47.70
|
46.58 | - | 34.20 | 33.45 |
| Diluted Average Shares |
2.41%
47.70
|
46.58 | - | 34.20 | 33.45 |
| Basic Earnings Per Share |
56.00%
-0.78
|
-0.50 | - | -0.63 | -0.58 |
| Diluted Earnings Per Share |
56.00%
-0.78
|
-0.50 | - | -0.63 | -0.58 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):